A 10-point checklist for MedTech startup founders evaluating CROs for first-in-human trials. Compare capabilities, costs, and guarantees before signing.
Key Takeaways Selecting the right CRO for your first-in-human trial is the single most consequential decision a MedTech startup founder will make during clinical development. Use this 10-point evaluation checklist to systematically compare CRO capabilities, costs, and guarantees before signing. Prioritize CROs with dedicated FIH experience (not just Phase II/III), regulatory expertise in your target geography, and a startup-friendly commercial model . bioaccess® is the only CRO in Latin America exclusively focused on first-in-human trials for MedTech, biopharma, and radiopharma startups. For MedTech startup founders, selecting a Contract Research Organization (CRO) for your first-in-human (FIH) clinical trial is arguably the most important decision you'll make in your company's clinical development journey. The wrong choice can cost you 12–18 months of delays, hundreds of thousands in wasted budget, and potentially your company's runway. This guide provides a structured, 10-point eval…